RxDoctor Payments DataLook up a doctor →

Heather Previs

Family · Stratford, CTNPI 1477000370

Payments from drug & device makers

$14,249in general payments, 2019–2025

Across 758 payments — averaging $18.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • GSK$2K
  • Lilly USA, LLC$1K
  • Novo Nordisk$1K
  • AbbVie$1K
  • Astellas Pharma US Inc$1K
  • plus $6K from 41 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)130$2,473
GSK82$1,564
Lilly USA, LLC78$1,246
Novo Nordisk58$1,109
AbbVie55$1,093
Astellas Pharma US Inc43$1,057
Exact Sciences34$636
Pfizer36$600
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC28$526
Amgen(2 entities)23$454
Boehringer Ingelheim18$338
Merck17$312
Sanofi-aventis U.S. LLC13$263
Teva Pharmaceuticals USA, Inc.11$205
Eisai Inc.15$189
Neurocrine Biosciences, Inc.7$182
Bayer10$180
Amarin Pharma, Inc.13$178
ANI Pharmaceuticals, Inc.5$126
Otsuka America Pharmaceutical, Inc.6$119
Sumitomo Pharma America, Inc.8$118
Corcept Therapeutics5$109
Idorsia Pharmaceuticals US Inc6$108
Ardelyx, Inc.4$103
Viatris Specialty LLC5$90
Inspire Medical Systems, Inc.3$86
Biohaven Pharmaceutical Holding Company Ltd.5$85
Mylan Specialty L.p.4$76
Azurity Pharmaceuticals, Inc.4$71
Endo Pharmaceuticals Inc.3$66
CMP Pharma, Inc.3$63
Scilex Pharmaceuticals Inc.4$59
Xeris Pharmaceuticals, Inc.2$46
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$41
E.r. Squibb & Sons, L.L.C.2$35
Kowa Pharmaceuticals America, Inc.2$30
Phathom Pharmaceuticals, Inc.4$27
Lundbeck LLC1$25
Heartflow, Inc.1$23
Arbor Pharmaceuticals, Inc.1$21
Novartis1$20
Actelion Pharmaceuticals US, Inc.1$18
Paratek Pharmaceuticals, Inc.1$18
Medtronic1$17
Currax Pharmaceuticals LLC1$16
Ironwood Pharmaceuticals, Inc1$16
Sunovion Pharmaceuticals Inc.1$13

How this compares

$14,249 in reported general payments places this provider in the 95th percentile of 1,596 family providers in Connecticut.

See all family providers in Connecticut →

Medicare billing

Part B allowed, 2024
$32,748
Medicare patients
109
Services billed
407

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Stratford

See the full list for Connecticut →

Where these figures come from

Is this you, or does something look wrong? →